Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2018, Article ID 1582173, 11 pages
https://doi.org/10.1155/2018/1582173
Research Article

Influence of Adalimumab on the Expression Profile of Genes Associated with the Histaminergic System in the Skin Fibroblasts In Vitro

1Department of Skin Structural Studies, Chair of Cosmetology, School of Pharmacy with Division of Laboratory Medicine in Sosnowiec, Medical University of Silesia, ul. Kasztanowa 3, 41-200 Sosnowiec, Poland
2Chair and Department of Molecular Biology, School of Pharmacy with Division of Laboratory Medicine in Sosnowiec, Silesian Medical University, ul. Jedności 8, 41-206 Sosnowiec, Poland
3Department of Internal Medicine and Rheumatology, School of Medicine in Katowice, Medical University of Silesia, ul. Ziołowa 45/47, 40-635 Katowice, Poland

Correspondence should be addressed to Dominika Wcisło-Dziadecka; lp.airetni@akcedaizdd

Received 11 September 2017; Revised 26 November 2017; Accepted 10 December 2017; Published 2 January 2018

Academic Editor: Marija Mostarica-Stojković

Copyright © 2018 Dominika Wcisło-Dziadecka et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. I. V. Litvinov, A. A. Bizet, Y. Binamer, D. A. Jones, D. Sasseville, and A. Philip, “CD109 release from the cell surface in human keratinocytes regulates TGF-β receptor expression, TGF-β signalling and STAT3 activation: relevance to psoriasis,” Experimental Dermatology, vol. 20, no. 8, pp. 627–632, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. H. Wang, T. Peters, and A. Sindrilaru, “TGF-beta-dependent suppressive function of Tregs requires wild-type levels of CD18 in a mouse model of psoriasis,” Journal of Clinical Investigation, vol. 118, no. 7, pp. 2629–2639, 2008. View at Google Scholar
  3. J. Szepietowski, Z. Adamski, G. Chodorowska et al., “Leczenie łuszczycy – rekomendacje ekspertów Polskiego Towarzystwa Dermatologicznego. Część II: łuszczyca umiarkowana do ciężkiej,” Przegląd Dermatologiczny, vol. 101, pp. 455–472, 2014. View at Publisher · View at Google Scholar
  4. A. W. Armstrong, C. T. Harskamp, and E. J. Armstrong, “Psoriasis and metabolic syndrome: a systematic review and meta-analysis of observational studies,” Journal of the American Academy of Dermatology, vol. 68, no. 4, pp. 654–662, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. U. Khalid, P. R. Hansen, G. H. Gislason et al., “Psoriasis and new-onset diabetes: a Danish nationwide cohort study,” Diabetes Care, vol. 36, no. 8, pp. 2402–2407, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Machado-Pinto, M. d. Diniz, and N. C. Bavoso, “Psoriasis: new comorbidities,” Anais Brasileiros de Dermatologia, vol. 91, no. 1, pp. 8–16, 2016. View at Publisher · View at Google Scholar
  7. A. Michalak-Stoma, A. Pietrzak, J. C. Szepietowski, A. Zalewska-Janowska, T. Paszkowski, and G. Chodorowska, “Cytokine network in psoriasis revisited,” European Cytokine Network, vol. 22, no. 4, pp. 160–168, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. M. A. Lowes, M. Suárez-Fariñas, and J. G. Krueger, “Immunology of psoriasis,” Annual Review of Immunology, vol. 32, pp. 227–255, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. W. R. Swindell, A. Johnston, J. J. Voorhees, J. T. Elder, and J. E. Gudjonsson, “Dissecting the psoriasis transcriptome: inflammatory- and cytokine-driven gene expression in lesions from 163 patients,” BMC Genomics, vol. 14, no. 1, article 527, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Kunz and S. M. Ibrahim, “Cytokines and cytokine profiles in human autoimmune diseases and animal models of autoimmunity,” Mediators of Inflammation, vol. 2009, Article ID 979258, 20 pages, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. Całkosiński, I. Bradley, and M. Dobrzynski, “Charakterystyka procesu zapalnego,” Postepy Higieny Medycyny Doswiadczalnej, vol. 63, pp. 395–408, 2009. View at Google Scholar
  12. J. R. Bradley, “TNF-mediated inflammatory disease,” The Journal of Pathology, vol. 214, no. 2, pp. 149–160, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. R. Tian, G. Hou, D. Li, and T. Yuan, “A possible change process of inflammatory cytokines in the prolonged chronic stress and its ultimate implications for health,” The Scientific World Journal, vol. 2014, Article ID 780616, 8 pages, 2014. View at Publisher · View at Google Scholar
  14. C. E. Joyce, X. Zhou, J. Xia et al., “Deep sequencing of small RNAs from human skin reveals major alterations in the psoriasis miRNAome,” Human Molecular Genetics, vol. 20, no. 20, pp. 4025–4040, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. E. Sonkoly, T. Wei, and P. C. J. Janson, “MicroRNAs: novel regulators involved in the pathogenesis of psoriasis?” PLoS ONE, vol. 2, no. 7, Article ID e0000610, 8 pages, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. J. E. Hawkes, G. H. Nguyen, M. Fujita et al., “microRNAs in Psoriasis,” Journal of Investigative Dermatology, vol. 136, no. 2, pp. 365–371, 2016. View at Publisher · View at Google Scholar · View at Scopus
  17. R.-Y. Huang, L. Li, M.-J. Wang, X.-M. Chen, Q.-C. Huang, and C.-J. Lu, “An exploration of the role of MicroRNAs in psoriasis: a systematic review of the literature,” Medicine, vol. 94, no. 45, Article ID e2030, 2015. View at Publisher · View at Google Scholar · View at Scopus
  18. N. S. Seifeldin, S. B. El Sayed, and M. K. Asaad, “Increased MicroRNA-1266 levels as a biomarker for disease activity in psoriasis vulgaris,” International Journal of Dermatology, vol. 55, no. 11, pp. 1242–1247, 2016. View at Publisher · View at Google Scholar · View at Scopus
  19. S. García-Rodríguez, S. Arias-Santiago, G. Blasco-Morente et al., “Increased expression of microRNA-155 in peripheral blood mononuclear cells from psoriasis patients is related to disease activity,” Journal of the European Academy of Dermatology and Venereology, vol. 31, no. 2, pp. 312–322, 2017. View at Publisher · View at Google Scholar
  20. G. Lerman, C. Avivi, C. Mardoukh et al., “MiRNA expression in psoriatic skin: Reciprocal regulation of hsa-miR-99a and IGF-1R,” PLoS ONE, vol. 6, no. 6, Article ID e20916, 13 pages, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Shahid, T. Tripathi, F. Sobia, S. Moin, M. Siddiqui, and R. A. Khan, “Histamine, histamine receptors, and their role in immunomodulation: an updated systematic review,” Open Immunology Journal, vol. 2, no. 1, pp. 9–41, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. H. Stark, “Histamine receptors,” Biotrend Reviews, vol. 11, pp. 1–9, 2007. View at Google Scholar
  23. P. Panula, M. Sundvik, and K. Karlstedt, “Developmental roles of brain histamine,” Trends in Neurosciences, vol. 37, no. 3, pp. 159–168, 2014. View at Publisher · View at Google Scholar · View at Scopus
  24. J. Szepietowski, Z. Adamski, and G. Chodorowska, “Rekomendacje Polskiego Towarzystwa Dermatologicznego dotyczące stosowania leków biologicznych w łuszczycy zwyczajnej i stawowej (łuszczycowym zapaleniu stawów),” Przegląd Dermatologiczny, vol. 97, pp. 1–13, 2010. View at Google Scholar
  25. S. Garces, J. Demengeot, and E. Benito-Garcia, “The immunogenicity of anti-TNF therapy in immune-mediated inflammatory diseases: a systematic review of the literature with a meta-analysis,” Annals of the Rheumatic Diseases, vol. 72, no. 12, pp. 1947–1955, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. M. E. Weinblatt, E. C. Keystone, D. E. Furst et al., “Adalimumab, a fully human anti-tumor necrosis factor α monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial,” Arthritis & Rheumatism, vol. 48, no. 1, pp. 35–45, 2003. View at Publisher · View at Google Scholar · View at Scopus
  27. L. B. A. Van De Putte, C. Atkins, M. Malaise et al., “Efficacy and safety of adalimumab as monotherapy in patients with rheumatoid arthritis for whom previous disease modifying antirheumatic drug treatment has failed,” Annals of the Rheumatic Diseases, vol. 63, no. 5, pp. 508–516, 2004. View at Publisher · View at Google Scholar · View at Scopus
  28. C. Monaco, J. Nanchahal, P. Taylor, and M. Feldmann, “Anti-TNF therapy: past, present and future,” International Immunology, vol. 27, no. 1, pp. 55–62, 2014. View at Publisher · View at Google Scholar · View at Scopus
  29. R. Nishikawa, H. Nagai, T. Bito et al., “Genetic prediction of the effectiveness of biologics for psoriasis treatment,” The Journal of Dermatology, vol. 43, no. 11, pp. 1273–1277, 2016. View at Publisher · View at Google Scholar · View at Scopus
  30. G. Murdaca, F. Spanò, M. Contatore, A. Guastalla, O. Magnani, and F. Puppo, “Pharmacogenetics of etanercept: Role of TNF-α gene polymorphisms in improving its efficacy,” Expert Opinion on Drug Metabolism & Toxicology, vol. 10, no. 12, pp. 1703–1710, 2014. View at Publisher · View at Google Scholar · View at Scopus
  31. A. Wegner, M. Szychta, and J. Kierkuś, “Rola terapii biologicznej w podtrzymaniu remisji u dzieci z chorobą Leśniowskiego i Crohna,” Pediatria Polska, vol. 88, no. 2, pp. 131–137, 2013. View at Publisher · View at Google Scholar
  32. D. Domżał–Magrowska, R. Talar-Wojnarowska, J. Kotynia, Ł. Durko, and E. Małecka- Panas, “Skuteczność i bezpieczeństwo terapii biologicznej w przebiegu chorobie Leśniowskiego – Crohna – doświadczenia własne,” Prz Gastroenterol, vol. 6, no. 5, pp. 304–309, 2011. View at Google Scholar
  33. K. Michaelis, K. Wallbrecht, A. Kerstan et al., “Modulating T cell functions does not alleviate chronic inflammatory skin lesions in K5.TGFβ1 transgenic mice,” Experimental Dermatology, vol. 19, no. 5, pp. 406–415, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. S. Hoffjan and S. Stemmler, “On the role of the epidermal differentiation complex in ichthyosis vulgaris, atopic dermatitis and psoriasis,” British Journal of Dermatology, vol. 157, no. 3, pp. 441–449, 2007. View at Publisher · View at Google Scholar · View at Scopus
  35. E. Tschachler, “Psoriasis: the epidermal component,” Clinics in Dermatology, vol. 25, no. 6, pp. 589–595, 2007. View at Publisher · View at Google Scholar · View at Scopus
  36. M. Gschwandtner, M. Mildner, V. Mlitz et al., “Histamine suppresses epidermal keratinocyte differentiation and impairs skin barrier function in a human skin model,” Allergy: European Journal of Allergy and Clinical Immunology, vol. 68, no. 1, pp. 37–47, 2013. View at Publisher · View at Google Scholar · View at Scopus
  37. T. Ruzicka and S. Glück, “Cutaneous histamine levels and histamine releasability from the skin in atopic dermatitis and hyper-IgE-syndrome,” Archives of Dermatological Research, vol. 275, no. 1, pp. 41–44, 1983. View at Publisher · View at Google Scholar · View at Scopus
  38. F. E. R. Simons and K. J. Simons, “The pharmacology and use of H1-receptor - antagonist drugs,” The New England Journal of Medicine, vol. 330, no. 23, pp. 1663–1670, 1994. View at Publisher · View at Google Scholar · View at Scopus
  39. M. Honardoost, E. Arefan, M. Soleimani, S. Soudi, and M. R. Sarookhani, “Development of insulin resistance through induction of miRNA-135 in C2C12 cells,” Cell, vol. 18, no. 3, pp. 353–361, 2016. View at Google Scholar · View at Scopus
  40. J. Pan, L. Lordier, D. Meyran et al., “The formin DIAPH1 (mDia1) regulates megakaryocyte proplatelet formation by remodeling the actin and microtubule cytoskeletons,” Blood, vol. 124, no. 26, pp. 3967–3977, 2014. View at Publisher · View at Google Scholar · View at Scopus
  41. Y.-N. Lin, J. R. Izbicki, A. König et al., “Expression of DIAPH1 is up-regulated in colorectal cancer and its down-regulation strongly reduces the metastatic capacity of colon carcinoma cells,” International Journal of Cancer, vol. 134, no. 7, pp. 1571–1582, 2014. View at Publisher · View at Google Scholar · View at Scopus
  42. G. Bongers, I. de Esch, and R. Leurs, “Molecular pharmacology of the four histamine receptors,” in Histamine in Inflammation, vol. 709 of Advances in Experimental Medicine and Biology, pp. 11–19, Springer US, Boston, Mass, USA, 2010. View at Publisher · View at Google Scholar
  43. F. E. R. Simons and K. J. Simons, “Histamine and H1-antihistamines: celebrating a century of progress,” The Journal of Allergy and Clinical Immunology, vol. 128, no. 6, pp. 1139–1150, 2011. View at Publisher · View at Google Scholar · View at Scopus
  44. M. Romanowska and M. Komoszyński, “Adenosine—neurotransmitter and neuromodulator in the central nervous system,” Postepy Biochemii, vol. 48, no. 3, pp. 230–238, 2002. View at Google Scholar · View at Scopus
  45. B. Ghaderi, S. Amini, F. Maroofi et al., “Adenosine deaminase activity in chronic lymphocytic leukemia and healthy subjects,” Iranian Journal of Cancer Prevention, vol. 9, no. 3, Article ID e5069, pp. 1–6, 2016. View at Publisher · View at Google Scholar · View at Scopus
  46. H. T. Lynch, O. Kosoko-Lasaki, S. W. Leslie et al., “Screening for familial and hereditary prostate cancer,” International Journal of Cancer, vol. 138, no. 11, pp. 2579–2591, 2016. View at Publisher · View at Google Scholar · View at Scopus
  47. I. Cheng, S. J. Plummer, C. Neslund-Dudas et al., “Prostate cancer susceptibility variants confer increased risk of disease progression,” Cancer Epidemiology, Biomarkers & Prevention, vol. 19, no. 9, pp. 2124–2132, 2010. View at Publisher · View at Google Scholar · View at Scopus
  48. L. Li, M. He, L. Zhou et al., “A solute carrier family 22 member 3 variant rs3088442 G3A associated with coronary heart disease inhibits lipopolysaccharide-induced inflammatory response,” The Journal of Biological Chemistry, vol. 290, no. 9, pp. 5328–5340, 2015. View at Publisher · View at Google Scholar · View at Scopus
  49. T. Kun and R. Dąbrowski, “Endoteliny w regulacji funkcji układu krążenia,” Polski Przegląd Kardiologiczny, no. 4, pp. 149–155, 2002. View at Google Scholar
  50. A. Bagnato, F. Spinella, and L. Rosanò, “Emerging role of the endothelin axis in ovarian tumor progression,” Endocrine-Related Cancer, vol. 12, no. 4, pp. 761–772, 2005. View at Publisher · View at Google Scholar · View at Scopus
  51. L. Rosanò, V. Di Castro, F. Spinella et al., “Combined targeting of endothelin a receptor and epidermal growth factor receptor in ovarian cancer shows enhanced antitumor activity,” Cancer Research, vol. 67, no. 13, pp. 6351–6359, 2007. View at Publisher · View at Google Scholar · View at Scopus
  52. J. Oleander, M. Stachowicz, and J. Szota, “Endotelina jako cel terapeutyczny w raku jelita grubego,” in Fram Przegląd Naukowy, vol. 9-10, pp. 6–9, 2008. View at Google Scholar
  53. I. Sacewicz, M. Wiktorska, T. Wysocki, and J. Niewiarowska, “Mechanizmy angiogenezy nowotworowej,” Postepy Higieny Medycyny Doswiadczalnej, vol. 63, pp. 159–168, 2009. View at Google Scholar
  54. C. Lock, G. Hermans, R. Pedotti et al., “Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis,” Nature Medicine, vol. 8, no. 5, pp. 500–508, 2002. View at Publisher · View at Google Scholar · View at Scopus
  55. S. L. Romero-Cordoba, I. Salido-Guadarrama, M. Rodriguez-Dorantes, and A. Hidalgo-Miranda, “miRNA biogenesis: biological impact in the development of cancer,” Cancer Biology & Therapy, vol. 15, no. 11, pp. 1444–1455, 2014. View at Publisher · View at Google Scholar · View at Scopus
  56. B. Hukowska-Szematowicz and B. Deptuła, “Biologiczna rola mikroRNA (miRNA) – nowe dane,” in Postępy Biologii Komórki, vol. 37, pp. 1–13, 2010. View at Google Scholar
  57. A. Stachurska, P. Stachurski, and M. Malecki, “MikroRNA w chorobach układu sercowo-naczyniowego,” Choroby Serca i Naczyń, vol. 8, no. 3, pp. 158–164, 2011. View at Google Scholar
  58. J. Mytych, “a znaczące – rola mikroRNA w powstawaniu, detekcji oraz leczeniu nowotworów na przykładzie nowotworu żołądka,” in Medical Review, vol. 3, pp. 366–372, 2012. View at Google Scholar
  59. A. Grenda, M. Budzyńsk, and A. Filip, “Biogeneza cząsteczek mikroRNA oraz ich znaczenie w powstawaniu i przebiegu wybranych zaburzeń hematologicznych,” in Postepy Higieny Medycyny Doswiadczalnej, vol. 67, pp. 174–185, 2013. View at Google Scholar
  60. N. Kavitha, S. Vijayarathna, S. L. Jothy et al., “MicroRNAs: Biogenesis, roles for carcinogenesis and as potential biomarkers for cancer diagnosis and prognosis,” Asian Pacific Journal of Cancer Prevention, vol. 15, no. 18, pp. 7489–7497, 2014. View at Publisher · View at Google Scholar · View at Scopus
  61. J. Zhang, S. Li, L. Li et al., “Exosome and exosomal microrna: trafficking, sorting, and function,” Genomics, Proteomics & Bioinformatics, vol. 13, no. 1, pp. 17–24, 2015. View at Publisher · View at Google Scholar
  62. D. Betel, M. Wilson, A. Gabow, D. S. Marks, and C. Sander, “The microRNA.org resource: targets and expression,” Nucleic Acids Research, vol. 36, no. 1, pp. 149–153, 2008. View at Publisher · View at Google Scholar · View at Scopus
  63. S. B. Krintel, C. Dehlendorff, M. L. Hetland et al., “Prediction of treatment response to adalimumab: A double-blind placebo-controlled study of circulating microRNA in patients with early rheumatoid arthritis,” The Pharmacogenomics Journal, vol. 16, no. 2, pp. 141–146, 2016. View at Publisher · View at Google Scholar · View at Scopus
  64. A. Pivarcsi, F. Meisgen, N. Xu, and E. Sonkoly, “Changes in the level of serum microRNAs in patients with psoriasis after antitumour necrosis factor-α therapy,” British Journal of Dermatology, vol. 169, no. 3, pp. 563–570, 2013. View at Publisher · View at Google Scholar · View at Scopus
  65. E. Sikora, W. Ptak, and K. Bryniarski, “Immunoregulacja poprzez interferencyjny RNA - mechanizmy, rola, perspektywy,” Postepy Higieny Medycyny Doswiadczalnej, vol. 65, pp. 482–495, 2011. View at Publisher · View at Google Scholar
  66. A. Wójtowicz, M. Baj-Krzyworzeka, and J. Baran, “Charakterystyka i znaczenie biologiczne mikropęcherzyków błonowych,” Postepy Higieny i Medycyny Doswiadczalnej, vol. 68, pp. 1421–1432, 2014. View at Publisher · View at Google Scholar